Who we are
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
We employ more than 43,000 people in 80 offices around the world, and market our products in 170 countries.
Facts & figures
16
production sites in nine countries (Algeria, Brazil, China, Denmark, France, Japan, Russia, UK and US).
39%
of our employees are located in Denmark.
10
research and development centres in five countries (China, Denmark, India, UK and US).
170
number of countries we provide access to our products.
A partner that helps bring your ideas to life
We work in close collaboration with leading universities and biotech companies worldwide to collaborate and speed up new drug discovery.
We continuously seek new partners with whom we share complementary capabilities and mutual interests, and openly share novel peptide and protein analogues, and antibodies for preclinical research.
We offer easy and free access to selected high-quality and well-characterised compounds to curious and passionate scientists from around the world.
Contact Us
Saxenda Liraglutide Injection
Mechanism of Action
How to Use Your Saxenda Pen
In Brief
Mode of Action
Safety
Efficacy
Weight Maintenance
How to Use
3 Year Data
